Leah Bell
Obstetrics & Gynecology · Pensacola, FLNPI 1245735042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $474, 7.7 times the $62 reported in 2022.
Across 56 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$254
- Mayne Pharma Commercial LLC$206
- Dexcom, Inc.$145
- Sumitomo Pharma America, Inc.$90
- AbbVie$72
- Organon$45
- plus $401 from 19 others
What the payments were for
- Food & beverage$1,212100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 12 | $254 |
| Mayne Pharma Commercial LLC | 4 | $206 |
| Dexcom, Inc. | 4 | $145 |
| Sumitomo Pharma America, Inc. | 6 | $90 |
| AbbVie | 3 | $72 |
| Organon | 4 | $45 |
| Shield Therapeutics Inc | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $39 |
| LSI Solutions Inc | 1 | $31 |
| Innovation Technologies Inc | 2 | $30 |
| Exeltis, USA Inc. | 2 | $28 |
| Bayer | 1 | $26 |
| Coopersurgical, Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Merck | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Vivus LLC | 1 | $14 |
| Davol Inc. | 1 | $13 |
| Pfizer | 1 | $13 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANNOVERA$123
How this compares
$1,212 in reported general payments places this provider in the 55th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $1,098 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Pensacola
- Paul LarosePensacola$21K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.